Thyrotoxicosis during pegylated interferon therapy in a patient with chronic hepatitis C virus.
Tran
Huy A
HA
D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D013971:Thyrotoxicosis / Q000139:chemically induced*
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b